Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-475295.0%
operating margin TTM
-515860.0%
revenue TTM
561.37 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -4.19 |
| peg ratio | -0.31 |
| price to book ratio | 3.23 |
| price to sales ratio | 21,544.58 |
| enterprise value multiple | -4.92 |
| price fair value | 3.23 |
profitability ratios | |
|---|---|
| gross profit margin | -740.0% |
| operating profit margin | -515860.0% |
| pretax profit margin | -475295.0% |
| net profit margin | -475295.0% |
| return on assets | -68.24% |
| return on equity | -65.29% |
| return on capital employed | -80.08% |
liquidity ratio | |
|---|---|
| current ratio | 13.11 |
| quick ratio | 13.11 |
| cash ratio | 3.53 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 56,885.25 |
| days of payables outstanding | 458.42 |
| cash conversion cycle | 56,426.83 |
| receivables turnover | 0.01 |
| payables turnover | 0.80 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | -11,463.56 |
| cash flow to debt ratio | -47.50 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.12 |
| cash per share | 1.85 |
| operating cash flow per share | -1.12 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -47.50 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Altimmune, Inc. (NASDAQ:ALT) reported earnings?
Altimmune, Inc. (ALT) published its most recent earnings results on 12-11-2024.
What is Altimmune, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Altimmune, Inc. (NASDAQ:ALT)'s trailing twelve months ROE is -65.29%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Altimmune, Inc. (ALT) currently has a ROA of -68.24%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ALT's net profit margin stand at?
ALT reported a profit margin of -475295.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ALT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 13.11 in the most recent quarter. The quick ratio stood at 13.11, with a Debt/Eq ratio of 0.01.